Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Opportunities for immunotherapy in childhood acute myeloid leukemia.

Blood advances - 26 Nov 2019

Lamble Adam J, Tasian Sarah K

Abstract excerpt

Clinical outcomes for children with acute myeloid leukemia (AML) have improved minimally during the past 4 decades despite maximally intensive chemotherapy, hematopoietic stem cell transplantation, and optimized supportive care. Chemoresistance and relapse remain major sources of childhood cancer-associated mortality and highlight the need for alternative treatment approaches. The remarkable recent success of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents, Immunological
Share to Cell Cycle Checkpoints
Share to Disease Susceptibility

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunomodulation

Share to Leukemia, Myeloid, Acute

Share to Molecular Targeted Therapy

Share to Recurrence

Share to T-Lymphocytes

Source

Open in PubMed Open full text

Identifiers

PMID: 31770440
DOI: 10.1182/bloodadvances.2019000357
PMCID: PMC6880897

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Opportunities for immunotherapy in childhood acute myeloid leukemia.PMID 31770440Read ↗

Molecular-Targeted Therapy of Pediatric Acute Myeloid Leukemia.Semantic proximity Read ↗

Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CMLSemantic proximity Read ↗

Treatment of acute myeloid leukemia in children: A practical perspective.Semantic proximity Read ↗

Progress and Prospects in Pediatric Leukemia.Semantic proximity Read ↗

An Overview of Targeted Therapies in Acute Myeloid LeukemiaSemantic proximity Read ↗

Treatment Approaches in Pediatric Acute Myeloid Leukemia: A Narrative ReviewSemantic proximity Read ↗

The hallmarks of hematopoietic stem cell transplantation for pediatric acute myeloid leukemiaSemantic proximity Read ↗

Therapies on the horizon for childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Future Directions in Allogeneic Stem Cell Transplantation in Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Overcoming Antigen Escape and T-Cell Exhaustion in CAR-T Therapy for LeukemiaSemantic proximity Read ↗

Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms.Semantic proximity Read ↗

Non-Immunotherapy Approaches for Relapsed or Refractory AML: An Update for 2024.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.